返回
N
Nanjing Medical University
学者数991
论文数261
被引数0
关联论文 (260)
发表时间
DUBHE-H-308 study protocol: rationale and adaptive design of a randomized, open-label, seamless phaseII/III trial of iparomlimab and tuvonralimab (QL1706)-based regimens versus sintilimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma杜伯-308研究方案:一项随机、开放标签、无缝II/III期试验的合理性与适应性设计,比较伊帕罗利单抗和图沃尼利单抗(QL1706)为基础方案与信迪利单抗联合贝伐珠单抗作为晚期肝细胞癌一线治疗的疗效
Future Oncology
IF2.6

